Freenome has initiated a clinical study to help bring an AI-Genomics blood test for colorectal cancer to the U.S. market.
News & Features
Grail raises $300 million in Series C round to give massive boost to the development of its liquid biopsy applications for cancer.
Where is the evolution of LSR use—for molders, formulators, and especially designers and device engineers—headed in the coming years?
Beta Bionics receives IDE approval from FDA to begin a clinical trial testing the iLet Bionic Pancreas System.
TAVR pioneer Edwards Lifesciences has released positive 30-day data of its Sapien 3 valve at EuroPCR.
Blue Earth Diagnostics’ LOCATE clinical study shows 59% of patients with suspected recurrent prostate cancer had a change in their management plan following an 18F fluciclovine PET/CT scan.
Johnson & Johnson’s Cerenovus has stiff competition in the stent retriever market from both Stryker and Medtronic.
An industry expert sits down to discuss the pros and cons of a subscription-based business model and how the trend is making its way into the medtech realm.
The Department of Homeland Security has warned in a report that there are cybersecurity vulnerabilities in Medtronic’s N’Vision clinical programmer.
For more expert advice on how to make the most of your medtech career, don't miss the panel discussion, "How Do I Keep My Job in Medtech (and Get a Raise) or Find a Better One?" at MD&M East, June 12-14, 2018, in New York City. Use promo code "MDDI" for 20% off conference registration and free...